Hainan Huluwa Pharmaceutical Group Co., Ltd. (SHA:605199)
China
· Delayed Price · Currency is CNY 7.06
-0.01 (-0.14%)
Mar 11, 2026, 3:00 PM CST
SHA:605199 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
| Net Income | -168.12 | -274.46 | 10.85 | 85.68 | 72.14 | 121.5 | Upgrade
|
| Depreciation & Amortization | 76.67 | 76.67 | 58.88 | 51.03 | 48.17 | 43.51 | Upgrade
|
| Other Amortization | 2.78 | 2.78 | 0.83 | 0.54 | 0.31 | 0.3 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.04 | -0.04 | 0.08 | 0.01 | 0.09 | 0.2 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.86 | 0.86 | - | 0.54 | 1.83 | 10.92 | Upgrade
|
| Loss (Gain) From Sale of Investments | -8.18 | -8.18 | -0.35 | -0.55 | -0.32 | -1.72 | Upgrade
|
| Provision & Write-off of Bad Debts | 4.09 | 4.09 | 15.58 | -0.23 | 3.23 | - | Upgrade
|
| Other Operating Activities | 201.49 | 44.43 | 33.35 | 22.89 | 12.65 | 11.41 | Upgrade
|
| Change in Accounts Receivable | 17.8 | 17.8 | -63.98 | -245.05 | -34.15 | -197.45 | Upgrade
|
| Change in Inventory | -173.06 | -173.06 | -74.9 | -6.06 | -28.79 | -35.84 | Upgrade
|
| Change in Accounts Payable | 165.42 | 165.42 | 48.19 | 326.9 | 20.38 | 64.07 | Upgrade
|
| Operating Cash Flow | 114.28 | -149.12 | 28.25 | 238.71 | 102.48 | 3.3 | Upgrade
|
| Operating Cash Flow Growth | 45.94% | - | -88.17% | 132.93% | 3005.68% | -97.72% | Upgrade
|
| Capital Expenditures | -85.02 | -156.23 | -489.2 | -392.32 | -137.62 | -59.42 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.07 | 0.07 | 0.08 | 0.26 | 0.11 | 0.08 | Upgrade
|
| Cash Acquisitions | - | - | -35.1 | - | - | - | Upgrade
|
| Divestitures | - | 13.68 | - | - | - | - | Upgrade
|
| Investment in Securities | - | - | - | -19.54 | 0.11 | 1.72 | Upgrade
|
| Other Investing Activities | - | - | - | - | - | -20 | Upgrade
|
| Investing Cash Flow | -84.95 | -142.48 | -524.21 | -411.6 | -117.1 | -77.62 | Upgrade
|
| Long-Term Debt Issued | - | 735.74 | 1,140 | 686.02 | 464.22 | 242.27 | Upgrade
|
| Long-Term Debt Repaid | - | -620.52 | -552.39 | -507.52 | -260.53 | -123.74 | Upgrade
|
| Net Debt Issued (Repaid) | -88.27 | 115.22 | 588.08 | 178.5 | 203.68 | 118.53 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | - | 173.12 | Upgrade
|
| Common Dividends Paid | -38.54 | -92.16 | -31.56 | -14.35 | -73.75 | -8 | Upgrade
|
| Other Financing Activities | 55.43 | -1.23 | -3.47 | - | 16.38 | -22.55 | Upgrade
|
| Financing Cash Flow | -71.38 | 21.83 | 553.06 | 164.15 | 146.32 | 261.1 | Upgrade
|
| Net Cash Flow | -42.04 | -269.77 | 57.1 | -8.74 | 131.7 | 186.79 | Upgrade
|
| Free Cash Flow | 29.26 | -305.35 | -460.95 | -153.61 | -35.14 | -56.12 | Upgrade
|
| Free Cash Flow Margin | 2.75% | -21.60% | -25.68% | -10.14% | -2.60% | -4.83% | Upgrade
|
| Free Cash Flow Per Share | 0.08 | -0.77 | -1.27 | -0.38 | -0.09 | -0.15 | Upgrade
|
| Cash Income Tax Paid | 116.48 | 147.75 | 133.28 | 138.47 | 124.58 | 149.62 | Upgrade
|
| Levered Free Cash Flow | 200.72 | -208.27 | -516.59 | -206.31 | -52.48 | -129.2 | Upgrade
|
| Unlevered Free Cash Flow | 227.45 | -188.43 | -505.19 | -195.06 | -43.81 | -123.51 | Upgrade
|
| Change in Working Capital | 4.73 | 4.73 | -90.98 | 78.81 | -35.62 | -182.82 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.